2 papers in the library · 6 citations · publishing 2025
American Journal of Bioethics July 1, 2025 Joel Janhonen, Juuso Kähönen, Joona Räsänen 5 citations
Daniel Villiger argues that a patient's ignorance about the outcomes of transformative treatments does not necessarily undermine their autonomy, challenging the view that such ignorance should prohibit access to these treatments.
American Journal of Bioethics January 1, 2025 Juuso Kähönen, Joel Janhonen, Joona Räsänen 1 citation
Psychedelic experiences are attracting growing attention from bioethicists, with recent scholarship indicating that these experiences raise distinct ethical questions about autonomy, authenticity, and the nature of the self. The text argues that the altered states induced by psychedelics challenge conventional bioethical frameworks, particularly regarding informed consent and the moral significance of transformative experiences. It suggests that bioethicists must reconsider how to evaluate the risks and benefits of psychedelic therapies, especially when the experiences themselves can fundamentally change a person's values and beliefs. The authors call for a more nuanced ethical analysis that accounts for the unique features of psychedelic experiences.